TRANSFUSION AND APHERESIS SCIENCE, vol.49, no.2, pp.295-301, 2013 (Journal Indexed in SCI)
Article / Article
Title of Journal :
TRANSFUSION AND APHERESIS SCIENCE
Allogeneic haematopoietic stem cell, transplantation, Deferasirox, Iron overload, Survival, PRETRANSPLANTATION SERUM FERRITIN, MYELODYSPLASTIC SYNDROMES, MARROW-TRANSPLANTATION, THERAPY, ICL670, MORTALITY
Introduction: Iron overload (10) has been shown to be an important cause of mortality and morbidity in patients who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT). This study aimed to evaluate the possible effect of oral iron-chelation treatment (deferasirox) on survival in alloHSCT recipients in the posttransplant period.